GAL1704

GAL1704 · Galderma R&D

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GAL1704, covering 2022-05-31 to 2022-05-31. Get the full timeline:

Most recent: Clinical Trial Update: GAL1704 for Cheek Augmentation and Correction of Midface Contour Deficiencies [NA]